INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2014

Daily sulforaphane derived from broccoli sprout extracts significantly improved behavioral measures in young men with moderate to severe autism spectrum disorder.

In a randomized trial, 44 young men aged 13-27 with moderate to severe ASD received daily oral sulforaphane (50-150 µmol; n=29) or placebo (n=15) for 18 weeks, followed by 4 weeks without treatment. After 18 weeks, the placebo group experienced minimal change (<3.3%), while the sulforaphane group showed a 34% decline on the ABC (P < 0.001) and a 17% decline on the SRS (P = 0.017), indicating behavioral improvement. On the CGI-I, significantly more participants receiving sulforaphane showed improvement in social interaction, abnormal behavior, and verbal communication (P = 0.015-0.007). Scores on all scales returned toward pretreatment levels after treatment discontinuation.

Study type
Placebo-controlled, double-blind, randomized trial
Who was studied
44 young men (aged 13-27) with moderate to severe autism spectrum disorder (29 sulforaphane, 15 placebo)
What was measured
Behavioral measures: Aberrant Behavior Checklist (ABC), Social Responsiveness Scale (SRS), and Clinical Global Impression Improvement Scale (CGI-I)

THE PAPER

Sulforaphane treatment of autism spectrum disorder (ASD).

Singh K, Connors SL, Macklin EA, Smith KD, Fahey JW, Talalay P, Zimmerman AW. Proc Natl Acad Sci U S A, 2014.

PubMed 25313065 ↗DOI 10.1073/pnas.1416940111 ↗

Brain & moodTop 21: Broccoli

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.